Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 8Observational 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Breast Neoplasms 695Neoplasms 613Prostatic Neoplasms 315Lung Neoplasms 308Colorectal Neoplasms 282Carcinoma, Non-Small-Cell Lung 254Pancreatic Neoplasms 178Carcinoma, Hepatocellular 168Stomach Neoplasms 139Multiple Myeloma 127Ovarian Neoplasms 120Melanoma 118Colonic Neoplasms 112Brain Neoplasms 108Hematologic Neoplasms 107Head and Neck Neoplasms 106Urinary Bladder Neoplasms 103Leukemia, Myeloid, Acute 102Esophageal Neoplasms 101Disease 100Uterine Cervical Neoplasms 89Neoplasm Metastasis 89Liver Neoplasms 88Rectal Neoplasms 85Lymphoma 84Precursor Cell Lymphoblastic Leukemia-Lymphoma 83Endometrial Neoplasms 76Carcinoma, Renal Cell 73Leukemia 63Recurrence 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Solid Tumor Cancer × 1 year × Clear all
NCT07268066 2025-12-18

AMethiST

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting
180 enrolled
Other solid neoplasm

Solid Tumor Cancer

NCT07046780 2025-07-02

A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Not yet recruiting
90 enrolled
Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡